Integra LifeSciences has received FDA clearance for their
Camino Flex Ventricular Catheter. This
catheter is designed to be used with Integra’s Camino Monitor which was
approved last year and is already used in over 800 centers across the United
States. This device is used with magnetic resonance imaging (MRI scans) and
gives clinicians a more advanced system that can monitor ICP independently even
when CSF flow cannot be measured, unlike competing catheters which depend on
CSF flow. Integra is not new to the neurosurgery
industry, but has an already existing product line that consists of: cranial
access kits and CSF drainage systems.
Their neurosurgery product line is their second largest segment, next to
orthopedics, and reported $278,992 in fourth quarter revenue in 2013 coming from their neurosurgery
segment. This figure represents
approximately one third of their total revenue for the respected quarter.
No comments:
Post a Comment